FindTrial
Sign In

Effects of pyruvate supplementation on improving cardiopulmonary function and repeated sprint exercise performance

Effects of pyruvate supplementation on improving cardiopulmonary function and repeated sprint exercise performance

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053936
Enrollment
Unknown
Registered
2021-12-04
Start date
2022-01-06
Completion date
Unknown
Last updated
2022-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise-induced metabolic acidosis

Interventions

Control group:0.1 g/kg/d maltodextrin for 7 days
Experimental group:0.1 g/kg/d sodium pyruvate for 7 days

Sponsors

Beijing Sport University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 24 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 24 years; 2. BMI between 18.5-23.9 kg/m2; 3. At least 5 years of football training experience, VO2max is more than 50 mm/kg/min.

Exclusion criteria

Exclusion criteria: 1. Suffering from hypertension, diabetes, cardiovascular or metabolic diseases; 2. Smoking and ingesting alcohol; 3. Taking an acid-base buffer within the past 6 months and throughout the study period.

Design outcomes

Primary

MeasureTime frame
Blood gas;Mean power output;Peak power output;—

Countries

China

Contacts

Public ContactFeng Lin

Beijing Sport University

lfeng@bsu.edu.cn+86 18810978906

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026